Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI PEPTIDE 2MG 5MG 10MG VIAL UMBRELLA Labs FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
senolytic peptide foxo4-dri human study FOXO4-DRI (Proxofim)